Contact Allergies to Dental Metal as a Possible Risk Factor for Oral Cancer
NCT ID: NCT00693550
Last Updated: 2011-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
115 participants
OBSERVATIONAL
2000-08-31
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is studying contact allergies to dental metal as a possible risk factor for oral cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Oral Bacteria in Patients With Dry Mouth
NCT00048685
Oral Manifestations of Aplastic Anemia
NCT00006300
Study of Variation Over Time in the Oral Microbiome
NCT02049398
Metallic Taste Before, During and After Treatment of Head and Neck Cancer
NCT03558789
Genotoxicity Assessment of Dental Implants in Gingival Epithelial Cells
NCT04540991
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Identify the relationship between intraoral metal contact allergy and epithelial carcinogenesis in patients with newly or previously diagnosed intraoral squamous cell carcinoma.
* Compare the prevalence of metal contact allergy in these patients with control data from other existing study populations.
OUTLINE: This is a multicenter study.
* Participants undergo metal patch testing using 27 metals\* commonly used in dental repairs that are part of the Mayo metal series. Metal patches are applied to the patient's back for 3 days and the back is read on days 3 and 5. Relevant patient data obtained from their medical and dental history, physical exam, laboratory values and treatment are documented.
NOTE: \*Healthy volunteers (control) undergo metal patch testing using 8 metals most commonly positive for contact allergens.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
metal patch tests
Twenty - seven (27) metal patch tests will be applied to the patient's back and left in place for 3 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets 1 of the following criteria:
* Newly or previously diagnosed oral squamous cell carcinoma
* Recruited from the otorhinolaryngology departments of Mayo Clinic Rochester and Mayo Clinic Arizona
* Healthy volunteer (control)
* No history of intraoral squamous cell carcinoma
* Employed at Mayo Clinic Rochester or Mayo Clinic Arizona
PATIENT CHARACTERISTICS:
* No immunosuppression
* No other conditions that interfere with patch testing
PRIOR CONCURRENT THERAPY:
* Not specified
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mayo Clinic Cancer Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James A. Yiannias, MD
Role: STUDY_CHAIR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDR0000589036
Identifier Type: OTHER
Identifier Source: secondary_id
497-00
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.